Embark Health Inc. (“Embark”) is pleased to update shareholders on the commissioning of its production facility in Delta, BC. where the production of bubble hash, rosin and dry sift has commenced.
Since securing its Health Canada processing licence on February 7, 2020, and securing occupancy and a business licence from the City of Delta on April 28, 2020, Embark has commissioned its equipment for the production of bubble hash, rosin and dry sift, and achieved the following milestones:
-
Benchmarking and optimization of cannabis biomass processing time to ensure the most effective length of treatment to ensure outputs with high purity while maintaining cost-effectiveness.
-
Optimization of equipment configuration through test runs to ensure equipment is effectively configured for the optimal balance of consistent throughput and purity.
-
Correlation between biomass quality and extraction output determines the most appropriate modality to unveil the purity and unique properties of our partner’s biomass.
-
Developing a revenue pipeline consisting of tolling, contract manufacturing and brokering orders.
Embark continues to move forward with plans for two brands set to launch in the recreational market. Embark is launching a Value brand and an Approachable Premium brand. Each brand will comprise a selection of solventless products within their respective portfolios. The brand product offerings and price points will address the demand for 2.0 solventless products within the different market segments.
In order to fulfil the increase in customer orders, production pipeline and achieve round the clock operations, Embark has begun the ramp up of its people strategy and is actively seeking candidates to join the Embark team.
Embark is pleased with Health Canada’s policy announcement May 12, 2020 regarding Operational Changes to Cannabis Program Requirements, which permits licensed producers to expand on existing facilities without requesting lengthy amendments to their licence. Refer to the Cannabis Licence Management Guide: Cultivation, Processing and Sale for Medical Purposes. “This amendment is significant and allows Embark to accelerate the remaining facility retrofits to add production modalities in our licensed facility in Delta, BC”, said Dr. Luc C. Duchesne, Chief Executive Officer of Embark Health.
Construction at Embark’s Woodstock facility has re-initiatied following COVID-19 related delays. During this time Embark has applied current market insights combined with Embark Delta data to modify the facility design and build. The company has heightened focus on value-add production for Embark Brands and Brand partnerships, thereby delivering on existing 2.0 products and the growing 3.0 product development and demand.
About Embark Health Inc.
Embark Health Inc. is an emerging leader in cannabis extraction, with a focus on unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. It is Embark’s mandate to pursue the best production processes throughout product innovation and development, manufacturing and take to market lifecycles. The result is unparalleled commercial and consumer extraction products. For more information, please visit www.embarkhealthinc.com.
FORWARD LOOKING STATEMENTS
This news release contains “forward-looking information” within the meaning of applicable securities laws including statements regarding the commencement of operations at the Delta facility, the terms of the proposed supply agreements, the provision of tolling services and contract manufacturing at the Delta facility, the ability for Embark to complete its business objectives, the ability for Embark to successfully launch its recreational brands and the ability of Embark to become a leader in cannabis extraction and other future developments. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.